News for Healthier Living
Wistar Scientists Develop DNA-delivered Immunotherapy that Targets Ovarian Cancer More Effectively
Wistar scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against ovarian cancer in preclinical studies.
July 17, 2026
July 25 2026July 24 2026July 23 2026July 22 2026July 21 2026July 20 2026July 17 2026July 16 2026July 15 2026July 14 2026July 13 2026July 12 2026
|
|
|
|
|